一种由柏柏林激活的特定超级增强剂调节EGFR介导的RAS-RAF1-MEK1/2-ERK1/2通路,诱导鼻癌自
Yao Wu1,2, Qunying Jia1, Qi Tang2
1Hunan Key Laboratory of Oncotarget Gene and Clinical Laboratory, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University and Hunan Cancer Hospital, Changsha, 410013, China.
Cellular & molecular biology letters
|June 29, 2024
概括
柏柏林 (BBR) 通过诱导一种特定的超级增强剂 (SE) 来抑制鼻癌 (NPC) 的生长和转移,该超级增强剂增强了表皮生长因子受体 (EGFR) 转录和自. 这种表观遗传机制为NPC提供了一个新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 鼻癌 (NPC) 是一种高度转移的恶性瘤,死亡率高.
- 柏柏林 (BBR) 在临床上用于减少NPC转移和复发,但其机制尚不清楚.
研究的目的:
- 阐明BBR抑制NPC生长,转移和入侵的机制.
- 确定超级增强剂 (SE) 和自在BBR抗NPC作用中的作用.
主要方法:
- RNA测序 (RNA-seq) 用于分析信号通路.
- 染色体免疫沉测序 (ChIP-seq) 用于识别SEs.
- 基因淘汰和淘汰的实验.
- 在小鼠模型中的体内研究.
主要成果:
- BBR通过诱导一种新的BBR特定的SE.来抑制NPC生长,转移和入侵.
- 这种SE增强了表皮生长因子受体 (EGFR) 转录,通过自活性激活了RAS-RAF1-MEK1/2-ERK1/2通路.
- EGFR在BBR诱导的自中发挥着关键作用,由LC3-II增加和p62抑制证明.
- 在SE knockdown中,逆转了BBR对NPC增殖和转移的抑制作用.
结论:
- 一个新的BBR特异性的SE表观遗传机制调节了自并抑制了NPC的进展.
- BBR的抗NPC作用是通过SE诱导的EGFR转录和随后的自介导的.
- 这项研究为BBR作为NPC的潜在治疗剂提供了理由.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
MAPK Signaling Cascades
5.4K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.4K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K


